Biocon

To offer Vildagliptin for diabetics in the UAE

Revenues were reported at Rs 861 crores

The facility, which is spread over 45,000 square feet, was commissioned in 2008

The company also launches Basalog One, a ready to use insulin glargine disposable pen, for better blood sugar management Biocon…

The IPO is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene Syngene International's (Syngene) Initial…

The price band for the offer has been fixed between Rs 240 and Rs. 250 per equity share of Rs 10 each

Foreign investment limit raised to 44 per cent

She is the only India-based business leader featuring on the list

She is the only India based business leader featuring on the list

PEG-G-CSF and Adalimumab enter phase II while patient recruitment for one insulin Glargine phase II study is complete Biocon has…